Halberd Corporation (OTCMKTS:HALB) stock More Than Doubled: But Why?
Those who might be on the hunt for stocks which clocked massive gains on Thursday might do well to take a look at the Halberd Corporation (OTCMKTS:HALB) stock. Yesterday, the company announced that it had sent a shipment of metallic nanoparticle samples which are conjugated to antibodies, Tau and Phosphorylated Tau, related to Alzheimer’s disease.
That was a major development for the company and the market reacted accordingly. The Halberd stock soared by as much as 126% yesterday after the news emerged as investors piled on to the stock in a big way.
The metallic nanoparticles were conjugated by the company, the materials were then shipped by GreenBioAZ to Youngstown State University. Once the samples reach the university, Dr. William G. Sturrus is going to start with the next stage of development.
At that stage, the conjugated Alzheimer’s Disease blocks are going to be eradicated through the laser eradication process that belongs to Halberd. The President and Chief Executive Officer of the company, William A. Hartman also spoke about the matter yesterday. He stated that the company is excited about the possibility of starting the testing process. Investors could consider keeping an eye on the stock today and see if it can manage to add to its gains.
Market Reaction:
On Thursday, HALB stock surged 126% at $0.0315 with more than 143.97 million shares, compared to its average volume of 4.22 million shares. The stock has moved within a range of $0.0140 – 0.0355 after opening the trade at $0.0140. Over the past 52-week, the stock has been trading within a range of $0.0038 – 0.1090.
